Editorial: Enhancing innate immunity in combination therapy for solid tumors

Editorial: Enhancing innate immunity in combination therapy for solid tumors

Saved in:

Bibliographic Details
Main Author:	David Pejoski
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Immunology
Subjects:	innate immunity combination therapy immuno-oncology solid tumor immunotherapy cancer
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1539027/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Editorial: Tumor microenvironment complexity and its therapeutic implications
by: Denner Santos dos Anjos, et al.
Published: (2025-01-01)

Innate immune cells in vascular lesions: mechanism and significance of diversified immune regulation
by: Jinjing Wu, et al.
Published: (2025-12-01)

Editorial: Mechanism explorations of enhancing immunotherapeutic sensitivity via mediating immune infiltration and programmed cell death in solid tumor microenvironment
by: Fang Zheng, et al.
Published: (2025-01-01)

Enhancing precision in cancer treatment: the role of gene therapy and immune modulation in oncology
by: Emile Youssef, et al.
Published: (2025-01-01)

Editorial: Innate and adaptive immune responses to viral infection
by: Stefania Varchetta, et al.
Published: (2025-01-01)

The success of the tumor immunotherapy: neutrophils from bench to beside
by: Meng Zhu, et al.
Published: (2025-01-01)

Opportunities and challenges of immuno-oncology: A bibliometric analysis from 2014 to 2023
by: Siqi Zhang, et al.
Published: (2025-12-01)

The role of cisplatin in modulating the tumor immune microenvironment and its combination therapy strategies: a new approach to enhance anti-tumor efficacy
by: Guandu Li, et al.
Published: (2025-12-01)

Editorial: Tertiary lymphoid structures (TLS) in the tumor immune microenvironment
by: Xinbo Gao, et al.
Published: (2025-01-01)

First-in-human phase 1 dose-escalation results with livmoniplimab, an antibody targeting the GARP:TGF-ß1 complex, as monotherapy and in combination with the anti–PD-1 antibody budigalimab in patients with advanced solid tumors
by: Toshio Shimizu, et al.
Published: (2024-10-01)

Corrigendum: First-in-human phase 1 dose-escalation results with livmoniplimab, an antibody targeting the GARP: TGF-ß1 complex, as monotherapy and in combination with the anti–PD-1 antibody budigalimab in patients with advanced solid tumors
by: Toshio Shimizu, et al.
Published: (2025-01-01)

New insights into the mechanisms of the immune microenvironment and immunotherapy in osteosarcoma
by: Cong Luo, et al.
Published: (2025-01-01)

Advances in CAR T cell therapy: antigen selection, modifications, and current trials for solid tumors
by: Safwaan H. Khan, et al.
Published: (2025-01-01)

A patient-derived HCC spheroid system to model the tumor microenvironment and treatment response
by: Emilie Crouchet, et al.
Published: (2025-02-01)

The impact of innate immune response on the efficacy of oncolytic viruses
by: Kirill N. Trachuk, et al.
Published: (2024-12-01)

The transcriptome of MHV‐infected RAW264.7 cells offers an alternative model for macrophage innate immunity research
by: Yun Liu, et al.
Published: (2025-01-01)

A review on intrathecal administration of medications for leptomeningeal metastases in solid tumors
by: Xuemei Wang, et al.
Published: (2025-02-01)

Multiomics characterization of breast angiosarcoma from an Asian cohort reveals enrichment for angiogenesis signaling pathway and tumor-infiltrating macrophages
by: Tun Kiat Ko, et al.
Published: (2025-01-01)

Cryo-thermal therapy reshaped the tumor immune microenvironment to enhance the efficacy of adoptive T cell therapy
by: Shicheng Wang, et al.
Published: (2024-11-01)

Effect of neutrophils on tumor immunity and immunotherapy resistance with underlying mechanisms
by: Jiali Yao, et al.
Published: (2025-01-01)

Nano-Oncologic Vaccine for Boosting Cancer Immunotherapy: The Horizons in Cancer Treatment
by: Chao Chen, et al.
Published: (2025-01-01)

The Importance of Lung Innate Immunity During Health and Disease
by: Gusty Rizky Teguh Ryanto, et al.
Published: (2025-01-01)

Multiplex immunohistochemistry to explore the tumor immune microenvironment in HCC patients with different GPC3 expression
by: Mingzhen Zhou, et al.
Published: (2025-01-01)

Current status and future prospects of molecular imaging in targeting the tumor immune microenvironment
by: Xiang Wang, et al.
Published: (2025-01-01)

The link between spreading depolarization and innate immunity in the central nervous system
by: Kadir Oguzhan Soylu, et al.
Published: (2025-02-01)

Advances in preclinical and clinical studies of oncolytic virus combination therapy
by: Wenlong Du, et al.
Published: (2025-02-01)

Effect of innate and induced immunity on infectious bursal disease pathogenesis
by: A. N. Semina
Published: (2023-09-01)

Urbanization enhances body condition, but not innate immune defences, in a common waterbird
by: Amelia Chyb, et al.
Published: (2025-01-01)

Understanding the role of the gut microbiome in solid tumor responses to immune checkpoint inhibitors for personalized therapeutic strategies: a review
by: Mi Young Lim, et al.
Published: (2025-01-01)

Side-stepping the guardian of the genome: current cancer therapeutics targeting mutant p53
by: Iulianna C. Taritsa, et al.
Published: (2025-01-01)

The effect of general versus spinal anesthesia on perioperative innate immune function in patients undergoing total hip arthroplasty
by: Lotte M. C. Jacobs, et al.
Published: (2025-01-01)

Infiltrating T lymphocytes and tumor microenvironment within cholangiocarcinoma: immune heterogeneity, intercellular communication, immune checkpoints
by: Yunyan Dai, et al.
Published: (2025-01-01)

Per- and polyfluoroalkyl substances alter innate immune function: evidence and data gaps
by: Drake W. Phelps, et al.
Published: (2024-12-01)

Interplay of swine acute diarrhoea syndrome coronavirus and the host intrinsic and innate immunity
by: Fei Zhao, et al.
Published: (2025-01-01)

Breaking the shield of solid tumors: a combined approach for enhanced efficacy of CAR-T cells
by: Marat Khaliulin, et al.
Published: (2024-11-01)

Systematic review of innate immune responses against Mycobacterium tuberculosis complex infection in animal models
by: Luisa Maria Nieto Ramirez, et al.
Published: (2025-01-01)

Orchestrating cancer therapy: Recent advances in nanoplatforms harmonize immunotherapy with multifaceted treatments
by: Rongwei Xu, et al.
Published: (2025-02-01)

The role of delays in innate and adaptive immunity to intracellular bacterial infection
by: Simeone Marino, et al.
Published: (2007-01-01)

Simple hypertrophic tonsils have more active innate immune and inflammatory responses than hypertrophic tonsils with recurrent inflammation in children
by: Qun Huang, et al.
Published: (2020-06-01)

Levamisole, as a viral vaccine adjuvant, induces robust host defense through the modulation of innate and adaptive immune responses
by: Gang Sik Kim, et al.
Published: (2025-01-01)